Current Issue

Sponsored
Keywords

Biosimilars - Related Content

THIS KEYWORD IS SPONSORED BY:

Insight & Intelligence™: Biggest Biotech Trends of 2012
Feature Articles: Where Downstream Operations Are Headed
BioPerspectives: Best Practices for Testing Biosimilarity During Clinical Trials
The market for biosimilars is growing rapidly. Here are things to keep in mind to stay on top of the deluge.
Assay Tutorials: New Method for “Fingerprinting” Biosimilars
Comparability Testing Platform for Biologics at Molecular Level Now Available
Point of View: Patient Safety Top Concern with Biosimilars
Standards for Interchangeability and Physician Notification of Substitutions Remain Key Issues

Biosimilars: 10 Drugs to Watch
April 29, 2013
Which innovator drugs are companies scrambling to copy?
Electronics Giants Set Sights on Biotech
April 2, 2013
Samsung, Sony eye life-sci’s higher growth as consumer electronics sales flatten.
Biosimilars: Not So Far So Fast
March 18, 2013
Regulatory issues are among the hurdles that are slowing down biosimilar production.
7 Biotech Trends for the Coming Year
January 7, 2013
What does 2013 hold for the industry?
Biggest Biotech Trends of 2012
December 31, 2012
GEN takes a look back at some key biopharma developments of the past 12 months.